BCG vaccination scars: an avoidable problem?
Injections and vaccinations are most often given into the outer aspect of the upper arm-on the grounds of safety and ease of access. The use ofthis site may result in the formation of hypertrophic or keloid scars' sufficiently unsightly for patients to seek surgery. Smallpox vaccination was the most common cause of these defects, but now that it is obsolete, BCG (bacille Calmette Guerin) immunisation is left as the principal offender. The incidence of hypertrophic or keloid scars resulting from BCG immunisation in Britain is not known, but elsewhere in the world the incidence of hypertrophic scars has been put at 28-330 % and of keloid scars from 2% to 4%o2 3 Several factors influence the risk of scar formation and the final appearance. 4 The skin in some areas of the body has a tendency to form hypertrophic scars-for example, the skin on the deltoid, the sternum, and the upper back.5 Any infection, especially if chronic, prolongs inflammation and increases the risk of a bad scar. Pigmented skins are also more liable to scar hypertrophy.
BCG inoculation results in the formation of a cell-mediated immune response to the bacterium. The vaccine is given intracutaneously (subcutaneous administration results in a cold abscess), and after three weeks a bluish red papule appears at the site of injection. This lesion reaches its maximum size at about six weeks, when the skin overlying it becomes thin and shiny and frequently ulcerates. The ulcer is typically about 5 mm diameter and usually heals by the 13th week. 6 A persistent infected ulcer in an area with poor scarring properties is a good recipe for an ugly scar. One survey carried out in Africa found that the shoulder region was the most frequent site of keloid formation; out of a total of 286 keloids, vaccination (almost a fifth) was second only to unspecified trauma as a predisposing factor. 7 Hypertrophic or keloid scars may be treated by pressure, surgery, radiotherapy, or steroids, either singly or in combination. The application of pressure sustained over several months using tailored elastic garments may limit or reduce the formation of hypertrophic or keloid scars.8 9 Careful excision of the scar or granulating area and subcuticular suture of the defect may effect good healing and decrease the chance of formation of a bad scar. Only too commonly, however, the incision is longer than the scar or lesion and is closed under tension with sutures placed remote from the margin of the wound. The result is a larger scar flanked by ugly suture marks. Occasionally, such an error is compounded by a further, wider excision and similar closure leading to a disastrous result. Excisional surgery is rarely effective in producing an improvement.10
The scar, especially if circular and raised, may best be treated surgically by shaving flat and covering with a thin split-skin graft taken from a donor site which must be unobtrusive, lest an ugly scar develops there. Low-dose superficial irradiation within a few days of surgery may reduce the risk of keloid formation after surgery but carries the risk in coloured skin of altered pigmentation within the field and around the scar.
Corticosteroids such as triamcinolone may be injected into the lesion either by needle or dermojet. Three or four infections at monthly intervals may cause progressive atrophy of the scar."12 Care must be taken not to inject subdermally or resorption of fat may cause a contour defect.
Prevention is the most effective approach. No matter how carefully BCG is given, the resulting chronic infection often causes an ugly scar. Even in the hands of the most experienced surgeon the results of treatment of these scars are often disappointing. The final scar may be flatter but may still be unsightly owing to its size, abnormal colour, and texture.
When other sites are used for vaccination the problem of obtrusive scarring can be overcome-or at least minimised. Some authorities recommend a site low down the arm, at the level of, or below, the insertion of the deltoid 13 14; use of this lower site reduces the incidence of hypertrophic or keloid scars.2 Alternatively, the inner aspect of the arm may be used; this has better scarring properties than the outer aspect and is also more concealed. Other possible sites are the thighs, buttocks, chest, and abdominal wall. The advantages that the concealed nature of those sites offer are somewhat offset by the difficulties of access, which makes them inconvenient for use in mass immunisation. In these circumstances the arm remains the easiest target, but the upper deltoid region should not be used for BCG inoculation. Mr Finsberg spoke only for the Department of Health and Social Security, and, as the Central Policy Review Staff told us in its report,' no fewer than 16 different Government departments have an interest in alcohol. Many of these departments-for instance, the Treasury-are much higher in the departmental pecking order than the Department of Health and Social Security, and some of these departmentsfor instance, the Department of Employment and the Board of Trade-are more interested in jobs and profits than in the nation's health. The DHSS is left with few resources and little good will to cope with the problems that result from Britain drinking twice as much as it did two decades ago.
The Central Policy Review Staff's report on alcohol policies (which the Government refused to publish in 1979 but which was published this year in Sweden by Professor Kettil Bruun, who also spoke at the conference) concluded that "neither the existing machinery within Government, nor the bodies outside it, provide the means for coherent formulation of policies... It recommended that an advisory council on alcohol policies should be established with associated internal coordinating arrangements. This recommendation, we suspect, is the one that particularly upset the Government and caused it to suppress the report. The Government does not want a coherent policy-it wants to have its cake and eat it. It wants the £3597m brought in through tax on alcohol, and the 750 000 jobs supplied by the drink trade, and the £500m
